益气活血清脑汤联合高压氧治疗气虚血瘀型眩晕的疗效观察

Curative Efficacy Observation of Qi-benefiting,Blood-activating,and Cephalocathartic Decoction Combined with Hyperbaric Oxygen in the Treatment of Qi-deficiency and Blood-stasis Type Vertigo

本研究应用益气活血清脑汤联合高压氧治疗气虚血瘀型眩晕患者,观察其临床治疗效果。通过随机选取2013年1月到2015年6月我院接诊的气虚血瘀型眩晕患者80例,根据其临床治疗方式的不同随机均分为研究组和对照组,40例对照组患者通过西药盐酸氟桂利嗪联合高压氧进行治疗,40例研究组患者通过益气活血清脑汤联合高压氧进行治疗,对比两组患者临床治疗效果。结果表明研究组患者治疗后LVA以及两组患者治疗后BVA和BA均较治疗前显著提高,研究组LVA、BVA和BA各指标治疗后值显著高于对照组(p<0.05);研究组患者治疗后TC、LDLC和TG较治疗前显著改善(p<0.05),HDLC与治疗前相比无显著改善(p>0.05);对照组治疗后TC和LDLC较治疗前显著改善(p<0.05),HDLC与TG较治疗前无显著改善(p>0.05);研究组患者治疗后TC改善情况显著优于对照组患者(p<0.05);研究组总治疗有效率(95.00%)显著高于对照组(80.00%)(p<0.05)。因此,益气活血清脑汤联合高压氧治疗气虚血瘀型眩晕临床治疗效果显著,值得进行临床推广。

In this research, we used qi-benefiting, blood-activating, and cephalocathartic decoction combined with hyperbaric oxygen to treat patients with qi-deficiency and blood-stasis type vertigo, and observed its clinical therapeutic effect. We randomly selected 80 patients with qi-deficiency and blood stasis type vertigo in our hospital from January 2013 to June 2015, and equally divided them into the research group and the control group according to the different methods of clinical treatment. We treated 40 patients in the control group with western flunarizine hydrochloride medicine and hyperbaric oxygen, and the rest 40 patients in the research group were treated with qi-benefiting, blood-activating, and cephalocathartic decoction and hyperbaric oxygen, and the clinical therapeutic effects of patients in two groups were compared. The results showed that after treatment the LVA of patients in the research group, the BA and BVA of patients in two groups were all significantly higher than before, and each index ofLVA, BVA and BA in the research group was significantly higher than that in the control group （p〈0.05）. The TC, LDLC and TG of patients after treatment in the research group were remarkably improved than before （p 〈0.05）, but there was no significant improvement in HDLC compared with before （p 〈0.05）. The LDLC and TC of patients after treatment in control group were significantly improved than before （19 〈0.05）, while there was no significant improvement in HDLC and TG （p 〈0.05）. After treatment, the improvement of TC of patients in the research group was obviously better than that in the control group （p〈0.05）; the total treatment efficiency （95%） of the research group was significantly higher than that of the control group （80%） （p〈0.05）. Therefore, the clinical curative efficacy of qi-benefiting, blood-activating, and cephalocathartic decoction combined with hyperbaric oxygen therapy in the treatment ofqi-deficiency and blood-stasis type vertigo was significant and worth clinical promotion.